Sun Pharma
Ask about this →0 mentions · last seen 6/5/2026
Signals
Patni family launches Raay Neo Pharma, targeting Tier 2/3 cities with 15-20% cheaper generics
Third-generation Patnis enter branded generics with a Tier 2/3 city play across UP, Bihar, MP, Jharkhand, Odisha and Maharashtra. Pricing undercuts incumbents by 15-20%, with ₹20-50 crore facility spend, ₹80 crore revenue targeted by FY27 and a ₹1,000 crore ambition in five years ahead of an eventual listing.
The Hindu BusinessLine · 5/31/2026, 2:01:27 PM
Pine Labs, Hyundai land on brokerage radar as analysts flag fresh stock picks
Brokerages spotlight Pine Labs and Hyundai among today's top picks, putting the payments rail and auto retailer in focus alongside ONGC, IndusInd Bank and Sun Pharma.
NDTV Profit · 5/27/2026, 2:33:37 AM
Pregabalin moved to Schedule H1; ₹1,800 cr segment faces tighter chemist compliance
Health Ministry has reclassified pregabalin under Schedule H1, mandating prescription-only sale, separate retailer registers and packaging warnings. Sun Pharma, Torrent, Intas and Micro Labs lead the ₹1,800 crore CNS segment now exposed to stricter chemist-counter controls and audit risk.
The Hindu BusinessLine · 5/22/2026, 4:49:45 PM
190+ companies report Q4FY26 today; Colgate, Eicher Motors headline consumer-facing prints
A heavy earnings docket on May 22 includes Colgate-Palmolive India and Eicher Motors among 190+ filers. Retail watchers will parse volume growth, rural recovery cues, gross margins amid input-cost shifts, and dividend signals alongside management commentary on FY27 demand.
NDTV Profit · 5/22/2026, 6:43:00 AM
Q4 earnings: ITC profit +5% to ₹5,113 cr; Nykaa nearly 4x; Honasa +176%
Consumer-facing names post sharp Q4FY26 prints. ITC net profit rose 5% YoY to ₹5,113 cr. Nykaa swung to ₹78.4 cr from ₹20.3 cr. Honasa Consumer surged 176% to ₹69 cr. Maruti Suzuki flagged price hikes up to ₹30,000 from June 2026, signalling cost pass-through across autos.
Mint · Markets · 5/22/2026, 1:27:46 AM